Clinical Trial Update: Immune Profile of Acute Myeloid Leukemia Patients Receiving Azacitidine Plus Venetoclax Induction Chemotherapy

View source ↗

Summary

A clinical trial update notes an ongoing study evaluating the immune profile of acute myeloid leukemia patients receiving azacitidine plus venetoclax induction …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• VIDAZA (AZACITIDINE)
• Venclexta (venetoclax)

Snippet

Sponsor: Mayo Clinic | Conditions: Acute Myeloid Leukemia | Status: RECRUITING